Drug-coated Balloons Healthcare Professionals

IN.PACT™ Admiral™ DCB

Inpact  Admiral

The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces reinterventions, and preserves future treatment options.1 The IN.PACT Admiral DCB is indicated for de novo, restenotic, or in-stent restenotic lesions up to 360 mm with reference vessel diameters of 4 to 7 mm in the superficial femoral or popliteal arteries.


Product Details


IN.PACT AV drug-coated balloon on white background
The IN.PACT™ AV drug-coated balloon (DCB) enables you to get ahead of AV fistula restenosis by treating the cause — not just the symptoms — of fistula stenosis so you can go longer between interventions and help preserve the fistula for dialysis.2 Product Details

Coronary Drug-Coated Balloon

Prevail™ DCB

Paclitaxel-coated PTCA balloon on a white background

Understand why the Medtronic paclitaxel-coated PTCA balloon is an effective treatment option for in-stent restenosis, de novo lesions, and small vessels. 3


Product Details



Laird J. IN.PACT SFA 5-year Results. Presented at VIVA 2018; Las Vegas, NV.


Results from the IN.PACT AV Access Clinical Trial found in the IN.PACT AV drug-coated balloon (DCB) Instructions For Use (IFU).


Prevail Instructions for Use